About AQEMIA
AQEMIA is a drug invention company dedicated to creating entirely new medicines to address major unmet medical needs.
At the core of our mission is QEMI, our proprietary molecule-invention platform, which uniquely combines cutting-edge science with advanced technology. Powered by physics-based modeling, statistical mechanics, and generative AI, QEMI allows our teams to design novel drug candidates from first principles.
What makes AQEMIA different is our commitment to true innovation: our research is dedicated to the invention of new molecular entities, not the refinement of existing ones. We focus on inventing never-before-seen molecules, without relying on experimental data, and advancing them into a growing pipeline of proprietary programs and strategic partnerships with leading pharmaceutical companies.
Our most advanced preclinical programs are currently in in vivo optimization, targeting diseases still waiting for effective treatments, offering our teams the opportunity to work on science that can make a real difference in people’s lives.
For more information, visit AQEMIA.com and our LinkedIn.
About our Team
AQEMIA brings together a diverse, multidisciplinary team of 65+ professionals based in Paris and London. Our scientists and engineers, including chemists, physicists, machine learning experts, and software engineers, work side by side to push the boundaries of early-stage drug discovery.
This close collaboration across disciplines is central to our approach, enabling us to tackle complex scientific challenges from first principles and translate cutting-edge ideas into novel therapeutic candidates. At AQEMIA, team members are encouraged to contribute their expertise, learn from one another, and play an active role in shaping the future of drug invention.
The role
As Principal Computational Chemist, you'll lead the development of cutting-edge computational chemistry pipelines within Aqemia’s Drug Discovery Platform. Collaborating with computational chemists, AI researchers, and drug discovery experts, you'll integrate innovations to accelerate novel therapeutic discovery.
This is our most senior individual contributor rank at Aqemia. This role is designed for a scientist at the state of the art of their field, with deep expertise and a strong track record of impactful contributions. The Principal Computational Chemist will oversee complex scientific projects, mentor scientists, and actively shape our scientific roadmap.
Polite note: this position does not involve manual compound design in Drug Discovery Programs.
Polite note: UK visa sponsorship not currently available for this role at this time
Aqemia’s Recruitment team leads all recruitment activities for the company. We will not recognise any notional ownership recruitment companies claim over candidates presented directly to hiring managers without our Recruitment team's consent. Unsolicited resumes sent to us from recruiters do not constitute any type of relationship between the recruiter and Aqemia, and we will not be obligated to pay fees should we hire from those resumes.
Why Join Us
At AQEMIA, we are driven by a bold mission: transforming the way drugs are discovered. Here, engineers don’t just build software, they help discover real drugs.
You’ll work at the intersection of AI, physics and chemistry, transforming bold scientific ideas into robust, production-grade tools that accelerate discovery.
DeepTech Mission : Build the platform that powers AI-driven drug discovery, combining quantum-inspired physics with generative models
Real-World Impact : Every feature shipped helps scientists prioritize molecules and design better candidates, faster
Modern Stack & Challenges : Python, FastAPI, Airflow, Snowflake, Kubernetes, ML workflows, scientific infra, data engineering at scale
High Ownership, High Impact : Engineers contribute to architecture, tooling, and scientific decision-making
Interdisciplinary Team : Collaborate with chemists, physicists, ML researchers, and product teams
Prime Locations : Central Paris or London offices, with 2 remote days/week
Strategic Traction : Backed by $100M in funding and a $140M partnership with Sanofi
Join us if you’re excited to shape the future of AI-driven drug discovery, and want your code to change the course of real diseases.
Meet Athena, Drug Discovery Program Leader
Meet Nicolas, Head of Drug Discovery Platform